Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids

TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, each expertly crafted with premium THC and enhanced with rare cannabinoids for a uniquely elevated experience. Along with these innovative vape offerings, Cronos is also unveiling new SOURZ by Spinach® Fully Blasted flavors, infused with rare cannabinoids.

The new lineup includes three new 1.2 gram vapes in the following formats:

• (Sativa): A refreshing, uplifting blend with a 1:10 CBC-to-THC ratio.
• (Indica): A dreamy, restful experience with a 1:10 CBN-to-THC ratio.
• (Hybrid): A blissful, relaxed high with a 1:10 CBG-to-THC ratio.
  
  
  
  

Designed for consumers who prioritize both potency and added value, these vapes deliver 1,000mg of THC without compromising on the unique benefits of rare cannabinoids. Each product features winterized, distilled cannabis extract for purity, combined with terpene-rich flavors inspired by renowned cultivars. All Spinach® vapes are crafted with ceramic heaters, stainless steel components, and food-grade materials to ensure quality and a smooth experience.

In addition to the Spinach® vape launch, Cronos is expanding its best-selling edible line, SOURZ by Spinach®, with the new Fully Blasted lineup with each package containing one 10mg THC gummy in bold, fruit-forward flavors:

• : Tropical mango and tangy lime flavors with 10mg CBC and 10mg THC per gummy.
• Peach and exotic passionfruit flavors with a balanced ratio of 10mg CBN and 10mg THC per gummy.
• : Strawberry and refreshing watermelon flavors with 10mg CBG and 10mg THC per gummy.
  
  
  
  

“We are thrilled to expand our Spinach® 1.2g vape and SOURZ by Spinach® Fully Blasted lineups with these innovative products that combine THC potency and the added benefits of rare cannabinoids. This new lineup will deliver what so many consumers are looking for: mouthwatering flavors, rare cannabinoid enhancers, and THC,” said Mike Gorenstein, Chairman, President, and CEO of Cronos Group. “Cronos is committed to delivering exceptional cannabis experiences that meet evolving consumer preferences. Our goal is to continually innovate and provide our adult consumers with high-quality, enjoyable cannabis experiences. These new flavors and formulations reflect our dedication to quality, innovation, and giving consumers more reasons to choose Spinach®.”



The launch is backed by the brand’s in-store trade marketing, with dedicated budtender education, digital placements, and enhanced point-of-purchase materials. For more information and availability, please visit: .

About Cronos Group Inc.



Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements

        

This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about product launches and innovations and the consumer experience with respect thereto; and the Company’s intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, which has been filed on SEDAR+ and EDGAR and can be accessed at and /edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Media Relations Contact:

Emily Whalen

Investor Relations Contact:

Harrison Aaron